Why is Bafna Pharma. falling/rising?

As of 08-Oct, Bafna Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 164.25, which reflects a decrease of Rs 3.35 or 2.0%. The stock has underperformed its sector by 1.34% today and has been on a downward trend for the last two days, resulting in a total drop of 3.95% during this period. Despite opening with a gain of 2% and reaching an intraday high of Rs 170.95, it ultimately fell to its current price, which is still significantly higher than its performance over the past month, where it has increased by 65.99%. However, the stock's delivery volume has decreased sharply by 57.82% compared to the 5-day average, indicating a decline in investor participation. In the broader market context, while Bafna Pharmaceuticals has shown impressive year-to-date returns of 114.71% compared to the Sensex's 4.65%, its recent performance contrasts sharply with the benchmark's positive movement, as the Sensex has gained 0.98% over the past week. This divergence suggests that while the stock has performed well over the longer term, its current decline may be influenced by short-term factors such as reduced trading volume and recent consecutive losses, which could be causing investor concern.